TAG ARCHIVES FOR current events

4
Jun2013

Research Ethics Roundup: The SUPPORT trial debate continues, avian flu makes news, and more

Tags:
4 Jun
No comments

by Maeve Luthin, JD, Project Coordinator

It’s been a busy two weeks in the research ethics world! Grab some iced coffee and take some time to catch up with current events.

Dirty Medicine: Earlier this month, generic drug manufacturer Ranbaxy pled guilty to federal criminal charges of selling adulterated drugs with the [...] Read more

9
May2013

Just how vulnerable are we? Just how are we vulnerable?

Tags:
9 May
No comments

by Dahron Johnson

Dahron Johnson has worked as the Chaplain for HighPoint Hospice in Gallatin, TN, as well as serving two and a half years as an Association for Clinical Pastoral Education chaplain resident and intern at the Department of Veterans Affairs' Tennessee Valley Health System’s Nashville campus. He continues to serve at the latter as a community member on the IRB, and is involved with other area ethics roundtables.<[...] Read more

6
May2013

Digging into the HIPAA/HITECH Act Omnibus Final Rule

Tags:
6 May
No comments

On Monday, March 4, PRIM&R hosted a webinar titled PRIM&R’s Primer on the HIPAA/HITECH Act Omnibus Final Rule. Emily Chi Fogler, JD, senior legal counsel in the Office of General Counsel at Partners HealthCare System, and Jennifer Geetter, JD, partner in the law firm of McDermott Will & Emery LLP, participated as speakers, with P. Pearl O’Rourke, MD, as moderator. Following the webinar, we connected with Emily Chi Fogler, and she kindly answered a few more questions that came in from webinar participants, for <[...] Read more

5
Apr2013

Research Ethics Roundup: The implications of publishing the HeLa genome without consent, new guidance on incidental findings, and more!

Tags:
5 Apr
No comments

Do April showers have you stuck indoors? Take a moment to peruse the latest installment of our Research Ethics Roundup. This week’s issue features articles on a wide range of topics, including how history should remember researchers with checkered pasts, why science tends to favor positive results, and much more.

Building public trust in genomic research: In this response to Read more